title: The pathophysiology, diagnosis, and treatment of dry eye disease.
abstract: BACKGROUND
  Dry eye disease (DED) is common; its prevalence around the world varies from 5% to 34%. Its putative pathogenetic mechanisms include hyperosmolarity of the tear film and inflammation of the ocular surface and lacrimal gland. Dry eye is clinically subdivided into two subtypes: one with decreased tear secretion (aqueous-deficient DED), and one with increased tear evaporation (hyperevaporative DED).
  
  
  METHODS
  This review is based on pertinent publications retrieved by a selective PubMed search and on the authors' own clinical and scientific experience.
  
  
  RESULTS
  The diagnostic evaluation of dry eye disease should include a detailed patient history, thorough split-lamp examination, and additional tests as indicated. Few randomized controlled therapeutic trials for dry eye have been published to date. Artificial tears of various kinds are recommended if the symptoms are mild. Lid hygiene is helpful in the treatment of hyperevaporative dry eye, while collagen or silicon plugs can be used for partial occlusion of the efferent lacrimal ducts to treat severe hyposecretory dry eye. The benefit of long-term topical anti-inflammatory treatment of moderate or severe dry eye disease with corticosteroids or cyclosporine A eye drops has been documented in clinical trials on a high evidence level. Orally administered tetraycycline derivatives and omega-3 or omega-6 fatty acids are also used.
  
  
  CONCLUSIONS
  The treatment of dry eye has evolved from tear substitution alone to a rationally based therapeutic algorithm. Current research focuses on pathophysiology, new diagnostic techniques, and novel therapies including secretagogues, topical androgens, and new anti- inflammatory drugs.
authors: Elisabeth M
authors: EM
authors: Messmer
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D015352:Dry Eye Syndromes / Q000145:classification / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D065346:Lubricant Eye Drops / Q000627:therapeutic use*; D008487:Medical History Taking / Q000379:methods*; D066167:Slit Lamp
chemical_list: D000893:Anti-Inflammatory Agents; D065346:Lubricant Eye Drops